EASD Diabetes & Cardiovascular Disease Study Group THE SECOND ANNUAL MEETING 5-7 November 2009 Cluj-Napoca, Romania City Plaza Conference Center

Chairpersons Antonio Ceriello, UK Nicolae Hancu, Romania

Scientific Committee

Antonio Ceriello, Carlo B. Giorda N. Hancu, J. Petrie, E. Standl, J. Tuomilehto, P. Valensi

ADVANCED PRELIMINARY PROGRAMME Day 1 Thursday, November 5, 2009 Time Title Presenter 13.00-14.00 LUNCH 14.00-14.30 Welcome N.Hancu Introduction to D&CVD Annual Meeting A. Ceriello Session 1: New Scenarios 14.30-14.50 How can we evaluate what we do? G. Vespasiani, Italy The “Annali AMD” Experience 14.50-15.10 Sleep Disorders and Diabetes Franco Cappuccio, UK 15.10-15.30 Glucose management in the hospital D. Tschoepe, Germany 15.30-15.50 Benefit-Risk evaluation of strict glycaemic G. Schernthaner, Austria control for the prognosis of Patients with type 2 diabetes 15.50-16.20 BREAK 16.20-16.50 Q&A guided session 16.50-18.10 Session 2: Oral presentations 18.05-18.20 Summary 18.30 WELCOME RECEPTION Day 2 Friday, November 6, 2009

Time Title Presenter Session 3: Emerging co-morbidities (1) 8.20-8.30 Welcome 8.30-8.50 Heart Failure and diabetes Helene von Bibra, Germany 8.50-9.20 Acute heart failure in diabetes G.E. Ambrosio, Italy 9.20-9.40 Silent CHD P.Valensi, France 9.40-10.00 BREAK 10.00-10.30 Q&A guided session 10.30-11.15 Session 4: Oral presentations Session 5: Emerging co-morbidities (2) 11.15-11.35 Acute coronary syndromes and diabetes S. Eckert, Germany 11.35-11.55 Cardiovascular Prevention in Type 2 Diabetes- Avner Lifshitz, Israel a primary care perspective 11.55-12.15 Drug Discovery & Translational Medicine I.M. Shah, UK research in the treatment of Diabetic nephropathy 12.15-12.45 Q&A guided session 12.45-13.15 General Assembly 13.15-14.45 LUNCH 13.45-14.45 POSTER PRESENTATION Session 6: New insights in vascular damage Chair 14.45-15.05 Using arterial stiffness indices as targets for JK Cruickshank, UK treatment 15.05-15.25 Postprandial endothelial dysfunction- A. Stirban, Germany therapeutic options 15.25-15.45 Q&A guided session 15.45-16.45 Session 7: Oral presentations 16.45-16.20 BREAK 16.20-18.20 Session 8: Oral presentations 18.20-19.00 Summary of the day 19.30 DINNER Day 3 Saturday, November 7, 2009

Time Title Presenter Session 9: Diabetes and CVD: an update in basic science 8.20-8.30 Welcome 8.30-8.50 Pharmacogenetics in diabetes E.R. Pearson, UK 8.50-9.10 Glycation of LDL and HDL and risk of Naila Rabbani, UK cardiovascular disease in diabetes 9.10-9.30 Translation of experimental AGE research to PJ. Thornalley, UK clinical diagnostics and therapeutics 9.30-9.45 BREAK 9.45-10.15 Q&A guided session 10.15- 11.45 Session 10: Oral presentations 11.45-13.00 Summary of the day Closing ceremony 13.00 LUNCH